Conditions: Gastric Adenocarcinoma; Gastro-esophageal Junction Adenocarcinoma
Interventions: Drug: Irinotecan; Drug: Ramucirumab; Genetic: Blood for angiome profiling; Genetic: Blood for cfDNA
Sponsors: Washington University School of Medicine; Eli Lilly and Company
Not yet recruiting - verified May 2017
from #ORL via a.lsfakia on Inoreader http://ift.tt/2p0VqXC
via IFTTT
http://ift.tt/2p1rI4R
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
A 53-year-old man with a history of Crohn's disease on infliximab, presented with several weeks of cough and dyspnoea. He had a right-si...
-
Author: Stergiou, George S. MD, PhD; Ntineri, Angeliki MD, MSc; Kollias, Anastasios MD, PhD Page: 2481-2484 http://ift.tt/2rxEjKo h...
-
Calcitonin gene-related peptide (CGRP) is one of the most potent endogenous vasodilators identified to date. The present study elucidates th...
-
Abstract A novel analytical-scale concept to improve reliability of detection and analysis of natural and processed wastewater samples from...
-
Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmap : Abstract Recent single institution clinical trial success...
-
Author: Trelle, Alexandra N.; Henson, Richard N.; Green, Deborah A. E.; Simons, Jon S. DOI: 10.1037/xlm0000412 Publication Date: POST A...
-
Résumé Zizyphus lotus (L.) Desf. ou le jujubier est une plante médicinale utilisée traditionnellement comme antiinflammatoire, antidiabéti...
-
AbstractBackground Cardiac sympathetic denervation (CSD) has been shown to reduce the burden of implantable cardioverter-defibrillator (ICD...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου